Brawn Biotech Ltd. has announced the closure of its trading window for designated persons and their immediate relatives.

Effective July 01, 2026, insiders cannot deal in company securities.

This window will remain closed until 48 hours after the declaration of the un-audited financial results for the quarter ended June 30, 2026. This measure ensures fair trading practices ahead of key financial disclosures.

The date for the Board meeting to consider these results will be announced later.